The structure of a plant-specific partitivirus capsid reveals a unique coat protein domain architecture with an intrinsically disordered protrusion
Persistent plant viruses could also be the commonest viruses in wild vegetation. A rising physique of proof for mutualism between such viruses and their hosts, means that they play an vital position in ecology and agriculture. Right here we current the capsid construction of a plant-specific partitivirus, Pepper cryptic virus 1, at 2.9 Å decision by Cryo-EM.
Structural options, together with the T = 1 association of 60 coat protein dimers, are shared with fungal partitiviruses and the picobirnavirus lineage of dsRNA viruses. Nonetheless, the topology of the capsid is markedly completely different with protrusions emanating from, and partly comprising, the binding interface of coat protein dimers.
We present {that a} disordered area on the apex of the protrusion just isn’t required for capsid meeting and represents a hypervariable website distinctive to, and attribute of, the plant-specific partitiviruses. These outcomes counsel a structural foundation for the acquisition of further features by partitivirus coat proteins that permits mutualistic relationships with numerous plant hosts.
Sulforaphane covalently interacts with the transglutaminase 2 most cancers upkeep protein to change its construction and suppress its exercise
Sort 2 transglutaminase (TG2) features as an vital most cancers cell survival protein in a variety of cancers together with epidermal squamous cell carcinoma. TG2 exists in open and closed conformations every of which has a definite and mutually unique exercise.
The closed conformation has GTP-binding/GTPase exercise whereas the open conformation features as a transamidase to catalyze protein-protein crosslinking. GTP-binding/GTPase exercise is required for TG2 upkeep of the aggressive most cancers phenotype.
Thus, figuring out brokers that convert TG2 from the closed to the open GTP-binding/GTPase inactive conformation is a vital most cancers prevention/remedy technique. Sulforaphane (SFN) is a vital diet-derived most cancers prevention agent that’s identified to own a reactive isothiocyanate group and has potent anticancer exercise.
Utilizing a biotin-tagged SFN analog (Biotin-ITC) and kinetic evaluation we present that SFN covalently and irreversibly binds to recombinant TG2 to inhibit transamidase exercise and shift TG2 to an open/prolonged conformation, resulting in a partial inhibition of GTP binding.
We additionally present that incubation of most cancers cells or most cancers cell extract with Biotin-ITC leads to formation of a TG2/Biotin-ITC advanced and that SFN remedy of most cancers cells inhibits TG2 transamidase exercise and shifts TG2 to an open/prolonged conformation. These findings determine TG2 as a direct SFN anticancer goal in epidermal squamous cell carcinoma.
Impact of Warmth Remedy on the Property, Construction, and Aggregation of Skim Milk Proteins
To review the mechanism of heat-induced protein aggregates, skim milk was heated at 55, 65, 75, 85, and 95°C for 30 s. Then, the sulfhydryl content material, floor hydrophobicity, and secondary construction of heat-treated skim milk have been studied. Treating skim milk at completely different temperatures induced a lower in sulfhydryl content material (75.9% at 95°C) and a rise in floor hydrophobicity (44% at 95°C) with a disrupted secondary construction containing random coil, β-sheet, and β-turn of skim milk proteins.
The change in these properties facilitated mixture formation via disulfide bonds and hydrophobicity interplay. Microstructural statement additionally confirmed the next diploma of aggregation when skim milk was heated at 85 and 95°C. The results of two-dimensional polyacrylamide gel electrophoresis demonstrated that the aggregates consisted of a excessive proportion of κ-casein, β-lactoglobulin, and different whey proteins.
Impact of ultrasonic remedy on the construction and purposeful properties of mantle proteins from scallops (Patinopecten yessoensis)
On this examine, scallop mantle protein was handled by ultrasound at completely different powers, after which analyzed by ANS fluorescent probes, round dichroism spectroscopy, endogenous fluorescence spectrum, DNTB colorimetry and in-vitro digestion mannequin to elucidate the structure-function relationship.
The outcomes indicated that ultrasound can considerably have an effect on the secondary construction of scallop mantle protein like enhancing hydrophobicity, decreasing the particle measurement, growing the relative contents of α-helix and lowering contents of β-pleated sheet, β-turn and random coil, in addition to altering intrinsic fluorescence depth with blue shift of most fluorescence peak.
However ultrasound had no impact on its main construction. Furthermore, the features of scallop mantle protein have been regulated by modifying its buildings by ultrasound. Particularly, the protein had the best efficiency in foaming property and in-vitro digestibility beneath ultrasonic energy of 100 W, oil binding capability beneath 100 W, water binding capability beneath 300 W, solubility and emulsification capability beneath 400 W, and emulsion stability beneath 600 W.
These outcomes show ultrasonic remedy has the potential to successfully enhance purposeful properties and high quality of scallop mantle protein, benefiting in complete utilization of scallop mantles.
An Integrative Method to Decide 3D Protein Constructions Utilizing Sparse Paramagnetic NMR Information and Bodily Modeling
Paramagnetic nuclear magnetic resonance (NMR) strategies have emerged as highly effective instruments for construction dedication of huge, sparsely protonated proteins. Nonetheless conventional functions face a number of challenges, together with a necessity for big datasets to offset the sparsity of restraints, the issue in accounting for the conformational heterogeneity of the spin-label, and noisy experimental knowledge.
Right here we suggest an integrative method to construction dedication combining sparse paramagnetic NMR with bodily modelling to deduce approximate protein structural ensembles. We use calmodulin in advanced with the sleek muscle myosin mild chain kinase peptide as a mannequin system.
Regardless of buying knowledge from samples labeled solely on the spine amide positions, we’re capable of produce an ensemble with a median RMSD of ∼2.eight Å from a reference X-ray crystal construction. Our method requires solely spine chemical shifts and measurements of the paramagnetic rest enhancement and residual dipolar couplings that may be obtained from sparsely labeled samples.
LZerD Protein–Protein Docking Webserver Enhanced With de novo Construction Prediction
Protein-protein docking is a useful gizmo for modeling the buildings of protein complexes which have but to be experimentally decided. Understanding the buildings of protein complexes is a key element for formulating hypotheses in biophysics relating to the purposeful mechanisms of complexes.
Protein-protein docking is a longtime method for circumstances the place the buildings of the subunits have been decided. Whereas the variety of identified buildings deposited within the Protein Information Financial institution is growing, there are nonetheless many circumstances the place the buildings of particular person proteins that customers need to dock will not be decided but.
Recombinant Mouse MARCO Protein (N-His) |
|||
| MBS2557470-001mg | MyBiosource | 0.01mg | EUR 160 |
Recombinant Mouse MARCO Protein (N-His) |
|||
| MBS2557470-005mg | MyBiosource | 0.05mg | EUR 285 |
Recombinant Mouse MARCO Protein (N-His) |
|||
| MBS2557470-5x005mg | MyBiosource | 5x0.05mg | EUR 1265 |
Recombinant Mouse MARCO protein (N-8His) |
|||
| CD00311-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 188 |
|
Description: Recombinant Mouse Macrophage Receptor MARCO is produced by our Mammalian expression system and the target gene encoding Gln70-Ser518 is expressed with a 8His tag at the N-terminus. |
|||
Recombinant Mouse MARCO protein (N-8His) |
|||
| CD00311-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | EUR 517 |
|
Description: Recombinant Mouse Macrophage Receptor MARCO is produced by our Mammalian expression system and the target gene encoding Gln70-Ser518 is expressed with a 8His tag at the N-terminus. |
|||
MARCO Protein, Mouse, Recombinant (His Tag) |
|||
| MBS8122662-01mg | MyBiosource | 0.1mg | EUR 395 |
MARCO Protein, Mouse, Recombinant (His Tag) |
|||
| MBS8122662-5x01mg | MyBiosource | 5x0.1mg | EUR 1635 |
MARCO Protein, Mouse, Recombinant (His Tag) |
|||
| E45M52845M1-100 | EnoGene | 100 ug | EUR 1046.77 |
Recombinant Mouse Marco Protein, His (Fc)-Avi-tagged |
|||
| Marco-5371M | Creative BioMart | 50ug | EUR 2398.4 |
|
Description: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
|||
Recombinant Mouse Macrophage receptor MARCO (Marco), partial |
|||
| MBS1473644-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1380 |
Recombinant Mouse Macrophage receptor MARCO (Marco), partial |
|||
| MBS1473644-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 1635 |
Recombinant Mouse Macrophage receptor MARCO (Marco), partial |
|||
| MBS1473644-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1380 |
Recombinant Mouse Macrophage receptor MARCO (Marco), partial |
|||
| MBS1473644-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1635 |
Recombinant Mouse Macrophage receptor MARCO (Marco), partial |
|||
| MBS1473644-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2190 |
Recombinant Human MARCO Protein |
|||
| RP02733 | Abclonal | 100μg | EUR 851.5 |
Recombinant Mouse Macrophage Receptor MARCO/MARCO (N-8His) |
|||
| CU63-10ug | Novoprotein | 10ug | EUR 157.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Macrophage Receptor MARCO/MARCO (N-8His) |
|||
| CU63-1mg | Novoprotein | 1mg | EUR 2008.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Macrophage Receptor MARCO/MARCO (N-8His) |
|||
| CU63-500ug | Novoprotein | 500ug | EUR 1399.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Macrophage Receptor MARCO/MARCO (N-8His) |
|||
| CU63-50ug | Novoprotein | 50ug | EUR 327.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Macrophage Receptor MARCO/MARCO (N-8His) |
|||
| AP76480 | SAB | 1mg | EUR 2369 |
MARCO Recombinant Protein (Rat) |
|||
| RP210899 | ABM | 100 ug | Ask for price |
MARCO Recombinant Protein (Human) |
|||
| RP018841 | ABM | 100 ug | Ask for price |
Recombinant Human MARCO Protein, N-His-SUMO |
|||
| MBS1564913-01mg | MyBiosource | 0.1mg | EUR 385 |
OPCD00816-10UG - MARCO Recombinant Protein |
|||
| OPCD00816-10UG | Aviva Systems Biology | 10ug | EUR 119 |
OPCD00816-50UG - MARCO Recombinant Protein |
|||
| OPCD00816-50UG | Aviva Systems Biology | 50ug | EUR 299 |
OPCD00817-10UG - MARCO Recombinant Protein |
|||
| OPCD00817-10UG | Aviva Systems Biology | 10ug | EUR 129 |
OPCD00817-50UG - MARCO Recombinant Protein |
|||
| OPCD00817-50UG | Aviva Systems Biology | 50ug | EUR 309 |
OPCD00816-200UG - MARCO Recombinant Protein |
|||
| OPCD00816-200UG | Aviva Systems Biology | 200ug | EUR 589 |
OPCD00817-200UG - MARCO Recombinant Protein |
|||
| OPCD00817-200UG | Aviva Systems Biology | 200ug | EUR 619 |
Mouse MARCO Protein, His Tag |
|||
| E40MOP1250 | EnoGene | 20ug | EUR 495 |
Mouse MARCO Protein, His Tag |
|||
| MAR-M5245 | ACROBIOSYSTEMS | 100ug | EUR 2749.9 |
|
Description: Mouse MARCO, His Tag (MAR-M5245) is expressed from human 293 cells (HEK293). It contains AA Gln 70 - Ser 518 (Accession # Q60754-1). |
|||
Recombinant Human Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1395818-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1390 |
Recombinant Human Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1395818-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 1645 |
Recombinant Human Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1395818-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1390 |
Recombinant Human Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1395818-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1645 |
Recombinant Human Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1395818-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2205 |
MARCO Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV199316 | ABM | 500 ng | EUR 723.6 |
MARCO Protein Vector (Mouse) (pPB-C-His) |
|||
| PV199314 | ABM | 500 ng | EUR 723.6 |
MARCO Protein Vector (Mouse) (pPB-N-His) |
|||
| PV199315 | ABM | 500 ng | EUR 723.6 |
MARCO Protein Vector (Mouse) (pPM-C-His) |
|||
| PV199317 | ABM | 500 ng | EUR 723.6 |
Recombinant Mesocricetus auratus Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1306658-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1335 |
Recombinant Mesocricetus auratus Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1306658-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 1590 |
Recombinant Mesocricetus auratus Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1306658-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1335 |
Recombinant Mesocricetus auratus Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1306658-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1590 |
Recombinant Mesocricetus auratus Macrophage receptor MARCO (MARCO), partial |
|||
| MBS1306658-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2150 |
MARCO Recombinant Rabbit mAb |
|||
| BS45989 | Bioworld Biotech | 50 ul | EUR 258 |
|
Description: Rabbit |
|||
Mouse Marco / Macrophage receptor MARCO ELISA Kit |
|||
| E9673m | EIAab | 96T | EUR 776 |
Mouse Macrophage Receptor With Collagenous Structure (MARCO) Protein |
|||
| 20-abx650074 | Abbexa |
|
|
Mouse Macrophage Receptor With Collagenous Structure (MARCO) Protein |
|||
| abx650074-100g | Abbexa | 100 µg | EUR 512.5 |
Mouse Macrophage Receptor With Collagenous Structure (MARCO) Protein |
|||
| abx650074-10g | Abbexa | 10 µg | EUR 212.5 |
Mouse Macrophage Receptor With Collagenous Structure (MARCO) Protein |
|||
| abx650074-50g | Abbexa | 50 µg | EUR 362.5 |
Mouse Macrophage Receptor MARCO (MARCO) ELISA Kit |
|||
| abx389793-96tests | Abbexa | 96 tests | EUR 1093.2 |
Mouse Macrophage receptor MARCO (MARCO) ELISA Kit |
|||
| RK13444 | Abclonal | 96T | EUR 280 |
Mouse Macrophage Receptor MARCO (MARCO) ELISA Kit |
|||
| MBS9345146-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Mouse Macrophage Receptor MARCO (MARCO) ELISA Kit |
|||
| MBS9345146-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Mouse Macrophage Receptor MARCO (MARCO) ELISA Kit |
|||
| MBS9345146-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Mouse Macrophage Receptor MARCO (MARCO) ELISA Kit |
|||
| MBS9345146-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Mouse Macrophage receptor MARCO, Marco ELISA KIT |
|||
| ELI-16328m | Lifescience Market | 96 Tests | EUR 1038 |
Recombinant Human MARCO, His-tagged |
|||
| MARCO-750H | Creative BioMart | 25ug | EUR 255.2 |
|
Description: The protein is stored in PBS buffer at -20℃. Avoid repeated freezing and thawing cycles. |
|||
Mouse MARCO Antibody |
|||
| GWB-Q01556 | GenWay Biotech | 0.25 mg | Ask for price |
Mouse MARCO Antibody |
|||
| GWB-D42395 | GenWay Biotech | 0.025 mg | Ask for price |
MARCO siRNA (Mouse) |
|||
| MBS8212597-15nmol | MyBiosource | 15nmol | EUR 405 |
MARCO siRNA (Mouse) |
|||
| MBS8212597-30nmol | MyBiosource | 30nmol | EUR 565 |
MARCO siRNA (Mouse) |
|||
| MBS8212597-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
Human MARCO Protein Lysate |
|||
| MBS8414979-002mg | MyBiosource | 0.02mg | EUR 365 |
Human MARCO Protein Lysate |
|||
| MBS8414979-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
Marco ELISA Kit| Mouse Macrophage receptor MARCO ELISA Kit |
|||
| EF015428 | Lifescience Market | 96 Tests | EUR 826.8 |
RAT ANTI MOUSE MARCO |
|||
| MBS215278-025mg | MyBiosource | 0.25mg | EUR 550 |
RAT ANTI MOUSE MARCO |
|||
| MBS215278-5x025mg | MyBiosource | 5x0.25mg | EUR 2295 |
RAT ANTI MOUSE MARCO |
|||
| MBS215282-0025mg | MyBiosource | 0.025mg | EUR 225 |
RAT ANTI MOUSE MARCO |
|||
| MBS215282-5x0025mg | MyBiosource | 5x0.025mg | EUR 835 |
Human MARCO Protein, His Tag |
|||
| MAR-H5243 | ACROBIOSYSTEMS | 100ug | EUR 2749.9 |
|
Description: Human MARCO, His Tag (MAR-H5243) is expressed from human 293 cells (HEK293). It contains AA Met 79 - Val 520 (Accession # Q9UEW3-1). |
|||
Mouse MARCO Antibody (RPE) |
|||
| GWB-Q01559 | GenWay Biotech | 100 TESTS | Ask for price |
Mouse MARCO shRNA Plasmid |
|||
| 20-abx971431 | Abbexa |
|
|
Mouse MARCO Antibody (FITC) |
|||
| GWB-3E5FC1 | GenWay Biotech | 0.05 mg | Ask for price |
Human MARCO Protein Lysate 20ug |
|||
| IHUMARCOPLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human MARCO Protein Lysate 20ug |
|||
Cynomolgus MARCO Protein, His Tag |
|||
| MAR-C5248 | ACROBIOSYSTEMS | 100ug | EUR 2749.9 |
|
Description: Cynomolgus MARCO, His Tag (MAR-C5248) is expressed from human 293 cells (HEK293). It contains AA Met 79 - Ile 520 (Accession # A0A2K5X0Z2-1). |
|||
OCOA11954-20UG - MARCO Protein Lysate |
|||
| OCOA11954-20UG | Aviva Systems Biology | 20ug | EUR 169 |
Marco (untagged) - Mouse macrophage receptor with collagenous structure (Marco), (10ug) |
|||
| MC217282 | Origene Technologies GmbH | 10 µg | Ask for price |
Marc1 (NM_001081361) Mouse Recombinant Protein |
|||
| E45M42299E1 | EnoGene | 50 ug | EUR 528.13 |
Marc2 (NM_133684) Mouse Recombinant Protein |
|||
| E45M47149M5 | EnoGene | 20 ug | EUR 1924.54 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPC614Mu01 | Cloud-Clone | 10ug | EUR 152 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| 4-RPC614Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Macrophage Receptor With Collagenous Structure expressed in: E.coli |
|||
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPC614Ra01 | Cloud-Clone | 10ug | EUR 160 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| 4-RPC614Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Macrophage Receptor With Collagenous Structure expressed in: E.coli |
|||
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPU51565-100ug | Biomatik Corporation | 100ug | EUR 492.8 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPU51565-1mg | Biomatik Corporation | 1mg | EUR 2184 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPU51565-50ug | Biomatik Corporation | 50ug | EUR 396 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPU51188-100ug | Biomatik Corporation | 100ug | EUR 468.6 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPU51188-1mg | Biomatik Corporation | 1mg | EUR 2074.8 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| RPU51188-50ug | Biomatik Corporation | 50ug | EUR 376.2 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033083-001mg | MyBiosource | 0.01mg | EUR 165 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033083-005mg | MyBiosource | 0.05mg | EUR 285 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033083-01mg | MyBiosource | 0.1mg | EUR 425 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033083-02mg | MyBiosource | 0.2mg | EUR 515 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033083-05mg | MyBiosource | 0.5mg | EUR 980 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033487-001mg | MyBiosource | 0.01mg | EUR 160 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033487-005mg | MyBiosource | 0.05mg | EUR 280 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033487-01mg | MyBiosource | 0.1mg | EUR 405 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033487-02mg | MyBiosource | 0.2mg | EUR 490 |
Recombinant Macrophage Receptor With Collagenous Structure (MARCO) |
|||
| MBS2033487-05mg | MyBiosource | 0.5mg | EUR 930 |
Marco (Myc-DDK-tagged) - Mouse macrophage receptor with collagenous structure (Marco) |
|||
| MR222739 | Origene Technologies GmbH | 10 µg | Ask for price |
Marco (GFP-tagged) - Mouse macrophage receptor with collagenous structure (Marco), (10ug) |
|||
| MG222739 | Origene Technologies GmbH | 10 µg | Ask for price |
Marco ORF Vector (Mouse) (pORF) |
|||
| ORF049829 | ABM | 1.0 ug DNA | EUR 607.2 |
MARCO Protein Vector (Rat) (pPM-C-HA) |
|||
| PV281204 | ABM | 500 ng | EUR 723.6 |
MARCO Protein Vector (Rat) (pPB-C-His) |
|||
| PV281202 | ABM | 500 ng | EUR 723.6 |
MARCO Protein Vector (Rat) (pPB-N-His) |
|||
| PV281203 | ABM | 500 ng | EUR 723.6 |
MARCO Protein Vector (Rat) (pPM-C-His) |
|||
| PV281205 | ABM | 500 ng | EUR 723.6 |
MARCO Protein Vector (Human) (pPM-C-HA) |
|||
| PV025123 | ABM | 500 ng | EUR 394.8 |
MARCO Protein Vector (Human) (pPB-C-His) |
|||
| PV025121 | ABM | 500 ng | EUR 394.8 |
MARCO Protein Vector (Human) (pPB-N-His) |
|||
| PV025122 | ABM | 500 ng | EUR 394.8 |
MARCO Protein Vector (Human) (pPM-C-His) |
|||
| PV025124 | ABM | 500 ng | EUR 394.8 |
Mouse MARCO HEK293 Overexpression Lysate |
|||
| MBS8116513-03mg | MyBiosource | 0.3mg | EUR 280 |
Mouse MARCO HEK293 Overexpression Lysate |
|||
| MBS8116513-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
March1 Recombinant Protein (Mouse) |
|||
| RP149426 | ABM | 100 ug | Ask for price |
March1 Recombinant Protein (Mouse) |
|||
| RP149429 | ABM | 100 ug | Ask for price |
March1 Recombinant Protein (Mouse) |
|||
| RP149432 | ABM | 100 ug | Ask for price |
March2 Recombinant Protein (Mouse) |
|||
| RP149444 | ABM | 100 ug | Ask for price |
March2 Recombinant Protein (Mouse) |
|||
| RP149447 | ABM | 100 ug | Ask for price |
March3 Recombinant Protein (Mouse) |
|||
| RP149450 | ABM | 100 ug | Ask for price |
March4 Recombinant Protein (Mouse) |
|||
| RP149453 | ABM | 100 ug | Ask for price |
March5 Recombinant Protein (Mouse) |
|||
| RP149456 | ABM | 100 ug | Ask for price |
March5 Recombinant Protein (Mouse) |
|||
| RP149459 | ABM | 100 ug | Ask for price |
March5 Recombinant Protein (Mouse) |
|||
| RP149462 | ABM | 100 ug | Ask for price |
March7 Recombinant Protein (Mouse) |
|||
| RP149468 | ABM | 100 ug | Ask for price |
March8 Recombinant Protein (Mouse) |
|||
| RP149471 | ABM | 100 ug | Ask for price |
MARCH9 Recombinant Protein (Mouse) |
|||
| RP149474 | ABM | 100 ug | Ask for price |
MARCKS Recombinant Protein (Mouse) |
|||
| RP149477 | ABM | 100 ug | Ask for price |
Recombinant Mouse MARCKS-related protein (Marcksl1) |
|||
| MBS718965-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1120 |
Recombinant Mouse MARCKS-related protein (Marcksl1) |
|||
| MBS718965-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 700 |
Recombinant Mouse MARCKS-related protein (Marcksl1) |
|||
| MBS718965-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 870 |
Recombinant Mouse MARCKS-related protein (Marcksl1) |
|||
| MBS718965-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 840 |
Recombinant Mouse MARCKS-related protein (Marcksl1) |
|||
| MBS718965-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1020 |
Mouse MARCO ELISA Kit PicoKine® |
|||
| EK2263 | BosterBio | 96 wells/kit, with removable strips. | EUR 750 |
|
Description: Mouse MARCO ELISA Kit PicoKine® (96 Tests). Quantitate Mouse MARCO in cell culture supernatants, serum and plasma (heparin, EDTA). Sensitivity: 150 pg/ml. |
|||
March10 Recombinant Protein (Mouse) |
|||
| RP149435 | ABM | 100 ug | Ask for price |
Right here, we now have built-in the AttentiveDist methodology for protein construction prediction into our LZerD webserver for protein-protein docking, which allows customers to easily submit protein sequences and procure full-complex atomic fashions, with out having to provide any construction themselves. We’ve got additional prolonged the LZerD docking interface with a symmetrical homodimer mode. The LZerD server is on the market.
